SRLF — SRLF 2026 atrial fibrillation in critically ill adults
SRLF, 2026
Assess reversible triggers and cardiac physiology before rate or rhythm treatment; weigh anticoagulation against bleeding in ICU context. This ICU-specific guidance contains 18 recommendations, 16 based on expert opinion and two on low-certainty evidence. Do not present it as high-certainty support for routine anticoagulation in every transient new-onset ICU AF episode.
Clinical Context & Relevant Topics (2)
Disease ReferenceAlgorithmic tachy- and bradyarrhythmia management, new-onset ICU atrial fibrillation, wide-complex tachycardia differentiation, and refractory Torsades overdrive pacing protocols.
UFH vs LMWH vs DTIs (Argatroban/Bivalirudin), anti-Xa vs aPTT monitoring, and emergency reversal (Protamine, 4F-PCC, Idarucizumab; historical andexanet evidence with current availability caveats).